DISINFECT plus combats hospital germs effectively
Experts call them “silent killers”: nosocomial pathogens, so-called hospital germs, trigger diarrhea, skin infections, pneumonia, urinary tract infections or sepsis in immunocompromised patients.
In Austria, around 65,600 patients are affected by hospital infections every year. In addition to the personal suffering of those who are affected, it also burdens the health system. DISINFECT plus GmbH offers the efficient DCX-technology using hydrogen peroxide dry steam.
The hospital as a source of risk
Nosocomial infections are a serious problem for every hospital. The dangerous pathogens by which patients are confronted in hospitals or nursing homes, are difficult to combat. Due to the high antibiotic consumption in the treatment of infectious diseases, bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) have become multi-resistant. They enter the body through open wounds or invasive medical procedures (venous or bladder catheters, respirators) and cause great damage there.
DISINFECT plus is effective against viruses and germs
The only remedy for hospital infections is strict hygiene and disinfection. However, there has been no device that guarantees both a high level of disinfection and a gentle impact on people and surrounding materials so far. This gap has been closed with the patented DCX-technology: the DISINFECT plus decontamination device, which works with micro-atomization of modified hydrogen, provides a cost-effective solution for room and surface disinfection in hospitals, retirement homes and laboratories.
Davul Ljuhar about DISINFECT plus
“Through enhanced hygiene and disinfection by DISINFECT plus, 20-30 % from the cases of infection can be avoided. For healthcare facilities, this means an evaluable decontamination process, an increase in hospital standards and fewer locks of departments due to infections. The DISINFECT plus pays off almost immediately: the acquisition costs correspond to the treatment costs for one MRSA sufferer. “ Dipl.-Ing. Davul Ljuhar, CEO of Braincon Technologies